Skip to main content
. 2022 Jun 11;76(5):1374–1382.e1. doi: 10.1016/j.jvs.2022.04.053

Table III.

Thrombotic events and procoagulant markers

N = 256
Venous thrombosis 153 (60%)
 Upper extremity 30 (20%)
 Lower extremity 101 (66%)
 Upper and lower extremities 13 (8%)
 Neck and thoracic veins 9 (6%)
Arterial thrombosis 60 (23%)
 Upper extremity 8 (14%)
 Lower extremity 47 (78%)
 Upper and lower extremity 3 (5%)
 Visceral thrombus 2 (3%)
Arterial and venous thrombosis 43 (17%)
Pulmonary embolism 72 (28%)
Myocardial infarction 14 (5%)
Aortic thrombus 4 (2%)
Stroke 3 (1%)
Multiple thrombotic locationsa 91 (35%)
Time of thrombosis from admission, daysa 4 [1-12]
Anticoagulation treatment 228 (89%)
Start of anticoagulation, daysb 2 [1-9]
DVT prophylaxis 157 (61%)
Surgery 30 (12%)
ICU 195 (76%)
Deceased 99 (39%)
D-dimer, μg/mL 8 (3-20)
Fibrinogen, μg/mL 383 (246-535)
PT, seconds 15 (15-18)
aPTT, seconds 38 (31-65)
Ferritin, μg/mL 808 (398-1409)
Antiphospholipid antibody, GLP 32 (1-35)

DVT, Deep venous thrombosis; GLP, immunoglobulin G phospholipid units; ICU, intensive care unit; PT, prothrombin time; aPTT, partial thromboplastin time.

Data are presented as number (%), mean (standard deviation), or median (interquartile range).

a

Time of thrombosis detection in days since hospital admission.

b

Start of anticoagulation treatment in days since hospital admission.